Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
29 April, 2017 09:06 IST
Piramal Enterprises concludes acquisition of drug portfolio from Mallinckrodt
Source: IRIS | 20 Mar, 2017, 10.28AM
Comments  |  Post Comment

Piramal Enterprises, one of India's largest diversified companies with a presence in pharmaceutical, financial services, announced that its wholly owned Critical Care subsidiary in the UK has completed its acquisition of a portfolio of drugs for spasticity and pain management from Mallinckrodt LLC (Mallinckrodt).

As indicated in the Press Release dated January 30, 2017, the acquisition was for a cash consideration of USD 171 million and up to an additional USD 32 million payable depending on financial performance of the acquired assets over the next three years.

The portfolio acquired includes Gablofen (baclofen), a severe spasticity management product, which is currently marketed in the United States, and two pain management products, which are currently under development. Gablofen has also been approved for launch in eight European markets.

Gablofen is the only intrathecal baclofen drug available in vials and pre-filled syringes, which are preferred by users over the competing products available in ampoules. The pain management drugs under development are also for intrathecal administration. In the twelve months ending September 30, 2016, the acquired portfolio generated revenues of USD 44.6 million.

Shares of the company gained Rs 9.25, or 0.5%, to trade at Rs 1,871.90. The total volume of shares traded was 217 at the BSE (10.17 a.m., Monday).



Piramal Enterprises Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Lupin receives USFDA approval for generic Benicar tablets - 28-Apr-2017 15:15
BHEL commissions 3 MW solar photovoltaic power plant - 28-Apr-2017 13:25
Reliance Capital Jan-Mar profit flat at Rs 4.17 bn - 28-Apr-2017 11:05
ICICI Bank opens new branch at Sanwer road in Indore - 28-Apr-2017 10:11
Kotak Bank to acquire entire 26% of Old Mutual's JV for Rs 12.93 bn - 28-Apr-2017 10:07
Kotak Mahindra Bank Q4 net jumps 40%; NII up 16% - 27-Apr-2017 16:39
TVS Motor Company quarterly profit falls 7% - 27-Apr-2017 16:22
Tata Motors signs contract with Defence Ministry for supply of 3,192 vehicles - 27-Apr-2017 16:18
Maruti Suzuki India quarterly earnings up 16% - 27-Apr-2017 16:08
R-Cap's insurance arm's FY17 profit before tax jumps 32% - 27-Apr-2017 12:40
National Green Tribunal orders Jubilant's 13 units to cease ops - 27-Apr-2017 11:16
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer